Theravectys SA - Product Pipeline Review - 2016

  • ID: 3960487
  • Company Profile
  • 44 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Dompe Farmaceutici S.p.A.
  • Syntrix Biosystems, Inc.
  • Vaccibody AS
  • MORE
Theravectys SA - Product Pipeline Review - 2016

The report ‘Theravectys SA - Product Pipeline Review - 2016’, provides an overview of the Theravectys SA’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Theravectys SA, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Theravectys SA
- The report provides overview of Theravectys SA including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Theravectys SA’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Theravectys SA’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Theravectys SA’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Theravectys SA
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Theravectys SA’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Dompe Farmaceutici S.p.A.
  • Syntrix Biosystems, Inc.
  • Vaccibody AS
  • MORE
Introduction

Theravectys SA Snapshot

Theravectys SA Overview

Key Facts

Theravectys SA - Research and Development Overview

Key Therapeutic Areas

Theravectys SA - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Theravectys SA - Pipeline Products Glance

Theravectys SA - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Theravectys SA - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Theravectys SA - Drug Profiles

Cellular Immunotherapy to Inhibit PD1 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Cellular Immunotherapy to Target CD33 and CD123 for AML - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Cellular Immunotherapy to Target CTLA4 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Cellular Immunotherapy to Target PDL1 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Epstein-Barr virus vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

hepatitis B vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

THV-01 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

THV-02 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

THV-03 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

THV-04 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Breast Cancer - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Glioblastoma Multiforme - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Hepatocellular Carcinoma - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for HPV Associated Cancers - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Melanoma - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Multiple Myeloma - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Ovarian Cancer - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine for Prostate Cancer - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine to Target CD274 and CD279 for Bladder Cancer - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine to Target CD274 and CD279 for Colorectal Cancer - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Vaccine to Target CD274 and CD279 for Renal Cell Carcinoma - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Theravectys SA - Pipeline Analysis

Theravectys SA - Pipeline Products by Target

Theravectys SA - Pipeline Products by Route of Administration

Theravectys SA - Pipeline Products by Molecule Type

Theravectys SA - Pipeline Products by Mechanism of Action

Theravectys SA - Dormant Projects

Theravectys SA - Locations And Subsidiaries

Head Office

List of Tables

Theravectys SA, Key Facts

Theravectys SA - Pipeline by Indication, 2016

Theravectys SA - Pipeline by Stage of Development, 2016

Theravectys SA - Monotherapy Products in Pipeline, 2016

Theravectys SA - Phase II, 2016

Theravectys SA - Preclinical, 2016

Theravectys SA - Pipeline by Target, 2016

Theravectys SA - Pipeline by Route of Administration, 2016

Theravectys SA - Pipeline by Molecule Type, 2016

Theravectys SA - Pipeline Products by Mechanism of Action, 2016

Theravectys SA - Dormant Developmental Projects,2016

List of Figures

Theravectys SA - Pipeline by Top 10 Indication, 2016

Theravectys SA - Pipeline by Stage of Development, 2016

Theravectys SA - Monotherapy Products in Pipeline, 2016

Theravectys SA - Pipeline by Target, 2016

Theravectys SA - Pipeline by Molecule Type, 2016

Theravectys SA - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Dompe Farmaceutici S.p.A.
- Syntrix Biosystems, Inc.
- Vaccibody AS
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll